TUNG ROGER has a total of 23 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are TREAMID THERAPEUTICS GMBH, PULMAGEN THERAPEUTICS INFLAMMATION LTD and PROXIMAGEN LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 23 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Tung Roger | 23 |
#2 | Masse Craig E | 3 |
#3 | Perni Robert | 2 |
#4 | Chandorkar Gurudatt | 2 |
#5 | Morgan Adam J | 1 |
#6 | Harbeson Scott | 1 |
#7 | Morgan Adam | 1 |
Publication | Filing date | Title |
---|---|---|
US2014128469A1 | Deuterated n-butyl bumetanide | |
US2012122944A1 | Tetrahydronaphthalene derivatives | |
US2011288126A1 | Substituted dioxopiperidinyl phthalimide derivatives | |
US2011144052A1 | Niacin prodrugs and deuterated versions thereof | |
US2011053964A1 | 4-aminoquinazoline derivatives and methods of use thereof | |
US2009093422A1 | Oxazolidinone derivatives and methods of use |